Linda-Gail Bekker

Linda-Gail Bekker
mmádu
ụdịekerenwanyị Dezie
mba o sịZimbabwe Dezie
aha enyereLinda, Gail Dezie
aha ezinụlọ yaBekker Dezie
ụbọchị ọmụmụ ya1962 Dezie
Ebe ọmụmụZimbabwe Dezie
Asụsụ obodoBekee Dezie
ọrụ ọ na-arụphysician, university teacher, HIV/AIDS activist Dezie
ụdị ọrụ yaimmunology Dezie
onye were ọrụUniversity of Cape Town, The Rockefeller University, Desmond Tutu HIV Foundation Dezie
Ọkwá o jipresident Dezie
ebe agụmakwụkwọUniversity of Cape Town, The Rockefeller University Dezie
onye ndụmọdụ doctoralGilla Kaplan Dezie
oge ọrụ ya (mmalite)1987 Dezie
Onye òtù nkeInternational AIDS Society Dezie
Ihe nriteAlan Pifer Research Award, Royal Society Africa Award, Fellow of the International Science Council Dezie

Linda-Gail Bekker MBChB, DTMH, DCH, FCP (SA) bụ Prọfesọ nke Medicine na onye isi ọrụ nke Desmond Tutu HIV Foundation. Ọ bụkwa onye isi ụlọ ọrụ Desmund Tutu HIV Center na Mahadum Cape Town. Ọ bụ onye isi ala gara aga nke International AIDS Society (2016-18).[1]

Mbido ndụ na agụmakwụkwọ

dezie

A mụrụ Bekker na Zimbabwe . [2] Ọ gụrụ ọgwụ na Mahadum nke Cape Town . [3] O bu n'obi ịghọ onye dibia bekee, ma mechaa ntụgharị ụlọ ọgwụ na KwaZulu-Natal wee nwee mmasị na nyocha HIV na TB.[4] Ọ hụrụ ndị na-eto eto na-anwụ site na HIV / AIDS ma nwee nkụda mmụọ na ọ pụghị inyere ha aka.[5] Ọ bụ John E. Fogarty International Center kwadoro Ph.D. ya.[2] Ọ rụrụ ọrụ na Mahadum Rockefeller na immunology.[2] Onye ndụmọdụ doctoral ya bụ Gilla Kaplan ma ya na ya na-arụkọ ọrụ taa.[6][5]

Nnyocha na ọrụ

dezie

N'afọ 2009, o ritere Ihe nrite Royal Society Pfizer Award maka nchọpụta ya gbasara ọrịa ụkwara nta.[7][8] Ego ahụ kwadoro nyocha ya na Nyanga Primary Health Clinic na Cape Town. [8] Bekker nwere mmasị na itinye aka na obodo na mmemme agụmakwụkwọ ndị ọgbọ na-eduzi.[9] Ọrụ obodo ya na-achọ imeri ihere metụtara HIV na ụkwara nta.[10]Desmond Tutu HIV Foundation, ebe Bekker na-eje ozi dị ka onye isi ọrụ, na-akwado ọdịmma nke ndị mmadụ na obodo ndị kasị daa ogbenye na South Africa.[11] Di ya, Robin Wood, na-eje ozi dị ka onye nduzi na onye isi oche. [12] Ọ mepụtara ụgbọ ala ahụike mkpanaka, nke a maara dị ka Tutu tester, nke na-enye nyocha maka ịtụrụ ime, ọbara mgbali elu, ọrịa shuga, HIV / AIDS, TB na oke ibu..[13][10] Ọ bụ onye nduzi nke Desmund Tutu HIV Centre na Mahadum nke Cape Town, ebe ọ na-ejikọta ọrụ kachasị mma na ihe akaebe gbasara ọgwụgwọ na mgbochi nke ndị na-eto eto na ikpo okwu siri ike.[14] Ụlọ ọrụ ahụ na-enweta ego site na National Institutes of Health . [15] Ọ mepụtara Nhọrọ maka Ụzọ Mgbochi Ndị Ntorobịa na South Africa (CHAMPS); nke na-ama aka omume ụmụ okorobịa na ibi úgwù, na-agba ụmụ agbọghọ ume ka ha na-eji mgbochi afọ ime ma nyochaa Pre-exposure prophylaxis.[16] Ọ rụkwara ọrụ na Nnyocha Ịmụ ime na HIV / AIDS Seeking Equitable (PHASES) nke National Institutes of Health kwadoro.[17] Ọ na-amụ banyere ọgwụgwọ antiretroviral. [18][19] Ọ na-enwe obi ụtọ maka nyocha onwe onye nke HIV.[20]

N'afọ 2016, a họpụtara ya ka ọ bụrụ onye isi oche nke International AIDS Society . [21] O nyere okwu mmeghe na International AIDS Society Conference na Paris, ebe o kwuru banyere nhọrọ mgbochi ọhụrụ dị ka Pre-exposure prophylaxis.[22] N'afọ 2018, a họpụtara ya ka ọ bụrụ onye otu International AIDS Vaccine Initiative . [14] Ọ na-enwe nchegbu banyere Donald Trump na-emebi nzaghachi nje HIV zuru ụwa ọnụ.[23][24] Ọ bụ onye isi okwu na World AIDS Day.

O nyere aka na The Conversation.[25][26][27][28] Bekker na-enwe mmasị ise ihe ma jiri ihe nkiri n'okporo ámá rụọ ọrụ obodo ya.[10]

Bekker na-eje ozi dị ka onye ndụmọdụ na President's Emergency Plan for AIDS Relief. [29]

Na 2024 International AIDS Conference na Munich, Prọfesọ Bekker gosipụtara nsonaazụ sitere na PURPOSE-1 ọmụmụ banyere mgbochi HIV site na iji lenacapavir injectable ugboro abụọ kwa afọ nke gosipụtara ịgba ọgwụ mgbochi ugboro abụọ kwa afọ na-echebe ụmụ nwanyị kpamkpam pụọ na nje HIV.[30] [31]Ọ dịghị onye sonyere na-anata ọrịa HIV ugboro abụọ n'afọ na akụkọ The New England Journal of Medicine.[32]

COVID-19

dezie

Bekker bụ onye nyocha na-eduzi, yana Glenda Gray, nke ikpe Sisonke nke zubere inye ndị ọrụ nlekọta ahụike na South Africa ohere ịnweta ọgwụ mgbochi COVID.[33] Nzọụkwụ 3b na-emeghe akara ahụike na-aga site na 17 Febụwarị 2021 ruo 15 Mee 2021, [34] na 478 733 doses nyere ndị ọrụ ahụike.[35][36] Nnyocha ahụ nwalere ịdị irè nke ọgwụ mgbochi Jansen (J&J) mgbe a na-enye ya n'ụzọ buru ibu n'okpuru ọnọdụ South Africa.[33]

Ihe odide

dezie
  1. Samarasekera (2021). "Linda-Gail Bekker—a leader at the service of the world". The Lancet Infectious Diseases 21 (6). DOI:10.1016/s1473-3099(21)00283-8. ISSN 1473-3099. PMID 34051192. 
  2. 2.0 2.1 2.2 Q and A with former Fogarty trainee Dr Linda-Gail Bekker (en-US). FIc. Retrieved on 2018-05-28.
  3. The NS Interview: Linda-Gail Bekker (en). www.newstatesman.com (5 November 2009). Retrieved on 2018-05-28.
  4. Vax Report - Vax Report (en-gb). www.vaxreport.org. Retrieved on 2018-05-28.
  5. 5.0 5.1 PHRI :: Gilla Kaplan, Ph.D.. www.phri.org. Archived from the original on 27 June 2003. Retrieved on 14 June 2021.
  6. Gilla Kaplan (en). Bill & Melinda Gates Foundation. Archived from the original on 11 September 2013. Retrieved on 14 June 2021.
  7. "South Africa: Linda-Gail Bekker Scoops Award for TB/HIV", Health-e (Cape Town), 2009-10-30. Retrieved on 14 June 2021.
  8. 8.0 8.1 African scientist wins award for HIV and TB co-infection research - Science News (en-gb). royalsociety.org. Retrieved on 2018-05-28.
  9. Professor Linda-Gail Bekker MBChB DTMH DCH FCP(SA) PhD | Infectious Disease & Molecular Medicine (en). www.idm.uct.ac.za. Archived from the original on 2018-05-29. Retrieved on 2018-05-28.
  10. 10.0 10.1 10.2 Linda-Gail Bekker: confronting the TB/HIV co-infection epidemic. The Lancet (2013-02-13). Retrieved on 2018-05-28.
  11. Linda-Gail Bekker (en). The Conversation (21 July 2016). Retrieved on 2018-05-28.
  12. "Desmond Tutu HIV Foundation | Background", Desmond Tutu HIV Foundation. Retrieved on 2018-05-28. (in en-GB)
  13. FABA (For Africa By Africans: Tutu Tester | Africa Strictly Business (en). www.africastrictlybusiness.com. Archived from the original on 2018-05-29. Retrieved on 2018-05-28.
  14. 14.0 14.1 "Board of Directors", IAVI - International AIDS Vaccine Initiative. Retrieved on 14 June 2021. (in en-gb)
  15. "Plenary Sessions - HIVR4P 2018", HIVR4P 2018. Retrieved on 14 June 2021. (in en-US)
  16. "CHAMPS", AVAC, 2014-03-18. Retrieved on 2018-05-28. (in en)
  17. Team (en-US). PHASES: Pregnancy & HIV/AIDS: Seeking Equitable Study. Retrieved on 2018-05-28.
  18. Conference Committees (en-US). www.aids2018.org. Retrieved on 2018-05-28.
  19. Bekker (2011-11-01). "TB and HIV co-infection: When to start antiretroviral therapy" (in en). Continuing Medical Education 29 (10): 420. ISSN 2078-5143. 
  20. "HIV Self-Test Granted CE Mark - Clinical Lab Products", Clinical Lab Products. Retrieved on 2018-05-28. (in en-US)
  21. "Bekker, Linda-Gail - Virology Education", Virology Education. Retrieved on 2018-05-28. (in en-US)
  22. "Professor Linda-Gail Bekker opens the International AIDS Symposium Conference | Desmond Tutu HIV Foundation", Desmond Tutu HIV Foundation, 2017-08-01. Retrieved on 14 June 2021. (in en-GB)
  23. Cutbacks in foreign aid for HIV treatment would produce great harm, generate few savings (en). Massachusetts General Hospital. Archived from the original on 29 May 2018. Retrieved on 14 June 2021.
  24. "More than 200 Scientists, Researchers and Clinicians including the co-discoverer of HIV Denounce Trump Administration Policies that Undermine the Global HIV Response", Health GAP (Global Access Project). Retrieved on 14 June 2021.
  25. Bekker. "Three decades on, stigma still stymies HIV prevention and treatment", The Conversation. Retrieved on 2018-05-28. (in en)
  26. Bekker. "Rings and things ... other ways to prevent HIV are on the cards", The Conversation. Retrieved on 2018-05-28. (in en)
  27. Bekker. "Explainer: the how, what and why of the latest HIV vaccine trial", The Conversation. Retrieved on 2018-05-28. (in en)
  28. Bekker. "AIDS conference 2016: the gains, the gaps, the next global steps", The Conversation. Retrieved on 2018-05-28. (in en)
  29. "Southern Africa: Update On the President's Emergency Plan for Aids Relief (Pepfar)", United States Department of State (Washington, DC), 2017-07-26. Retrieved on 14 June 2021.
  30. Lay. "Doctor behind trial of HIV prevention drug recounts breakthrough moment", The Guardian, 2024-07-26. Retrieved on 2024-07-27. (in en-GB)
  31. Sax (2024-07-25). Lenacapavir PrEP Trial Brings Down the House at the International AIDS Conference (en-US). HIV and ID Observations. Retrieved on 2024-07-27.
  32. Bekker (2024-07-24). "Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women" (in en). New England Journal of Medicine. DOI:10.1056/NEJMoa2407001. ISSN 0028-4793. PMID 39046157. 
  33. 33.0 33.1 Patel (16 March 2021). Trials, tinsel & tango: Go inside Linda-Gail Bekker's COVID world – Bhekisisa. Bhekisisa. Retrieved on 26 July 2021.
  34. J&J vaccines arrive in SA on Tuesday night. TimesLIVE (16 February 2021). Retrieved on 26 July 2021.
  35. Nair (15 May 2021). Final vaccine administered as part of Sisonke trial. TimesLIVE. Retrieved on 26 July 2021.
  36. Update On Covid-19 (16th May 2021). SA Corona Virus Online Portal (16 May 2021). Archived from the original on 17 May 2021. Retrieved on 26 July 2021.